Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts

Gastric cancer is one of the most malignant diseases and one of the leading causes of cancer-associated mortality worldwide. Although advances have been made in surgical techniques, perioperative management and the combined use of surgery with chemotherapy and/or radiotherapy, patients with advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, KAI, SONG, XILIN, ZHU, MEIRONG, MA, HENG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579967/
https://www.ncbi.nlm.nih.gov/pubmed/26622787
http://dx.doi.org/10.3892/ol.2015.3601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579967/
https://www.ncbi.nlm.nih.gov/pubmed/26622787
http://dx.doi.org/10.3892/ol.2015.3601

Ejemplares similares